Funded Startups in Aliso Viejo
Among the 14 most recent Aliso Viejo entries, the largest disclosed round is THOMAS JAMES HOMES at $400M (2025-11-04), which dwarfs every other disclosed a…
Among the 14 most recent Aliso Viejo entries, the largest disclosed round is THOMAS JAMES HOMES at $400M (2025-11-04), which dwarfs every other disclosed amount on the list; the next-highest disclosed figures are $250M (esVolta, 2026-06-03) and $140M (indie Semiconductor, 2022-11-17), with the rest clustered below $115M. Sector-wise, the list is led by life/health-adjacent categories (Biotechnology, Healthcare/Health Care, and Healthcare-related labels): Mammogen (Biotechnology, $30M on 2026-06-03), BrainChip (AI, $25M on 2025-12-10), Okami Medical (Healthcare/Hardware, $45M on 2025-11-17), RxSight (Biotechnology, $115M on 2024-05-08), and Spyglass Pharma (Administrative Services, $75M on 2025-06-02) sit alongside several tech and hardware entries.
The timing also shows clustering at the recent edge: 5 of 14 rounds (2025-11-04 through 2026-06-03) fall between the 2025-11-04 and 2026-06-03 dates (THOMAS JAMES HOMES $400M; esVolta $250M; Mammogen $30M; BrainChip $25M; Okami Medical $45M). A stage/label pattern stands out as well: 6 of 14 rows carry “Series Unknown,” and an additional 2 rows are marked “undisclosed” on amount (ThinkIQ on 2024-01-09; Massage Robotics on 2022-09-20). The oldest row shown is Syxsense (2021-05-03) with $6M, while the most recent is esVolta’s $250M round dated 2026-06-03.
Most recent rounds
14 shownRelated listings
Frequently asked
What stands out about the largest disclosed round in Aliso Viejo, and how does it compare to the rest of the list?
The largest disclosed amount is THOMAS JAMES HOMES at $400M (2025-11-04), which dwarfs the next-highest disclosed figures: esVolta at $250M (2026-06-03) and RxSight/indie Semiconductor at $115M/$140M (2024-05-08 and 2022-11-17). Most other disclosed rounds sit below $115M (for example, Spyglass Pharma at $75M on 2025-06-02 and Okami Medical at $45M on 2025-11-17).
Is there a tight date cluster among the most recent Aliso Viejo rounds?
Yes. Five of the 14 rows fall between 2025-11-04 and 2026-06-03: THOMAS JAMES HOMES ($400M on 2025-11-04), Okami Medical ($45M on 2025-11-17), BrainChip ($25M on 2025-12-10), Mammogen ($30M on 2026-06-03), and esVolta ($250M on 2026-06-03). The remaining entries extend back to 2021-05-03 (Syxsense).
How much of the dataset has undisclosed or unknown deal sizing/stage labels?
Stage is frequently not specified: 6 of 14 rows list “Series Unknown” (including esVolta on 2026-06-03 and Bright Uro on 2025-07-02). Amounts are also missing for 2 of 14 rows marked “undisclosed” (ThinkIQ on 2024-01-09 and Massage Robotics on 2022-09-20).
Which stage labels appear most often among the disclosed rows?
Beyond “Series Unknown,” the clearly labeled stages are relatively sparse: Spyglass Pharma shows “Series D” at $75M (2025-06-02), Mammogen is “Series A” at $30M (2026-06-03), indie Semiconductor is also disclosed as “Series Unknown” at $140M (2022-11-17), and one row shows “Equity Crowdfunding” (Massage Robotics, amount undisclosed, 2022-09-20). The dominance of unlabeled stage is consistent across the recency window and older entries.
Are any sectors over-represented in this Aliso Viejo slice?
Biotech/health-related labels recur more than other categories in this 14-row slice. Biotechnology appears in Mammogen ($30M on 2026-06-03) and RxSight ($115M on 2024-05-08); healthcare-related labels include Okami Medical (Healthcare/Hardware, $45M on 2025-11-17) and Bright Uro (Health Care, $15M on 2025-07-02), while Spyglass Pharma (Administrative Services, $75M on 2025-06-02) adds another health-adjacent entry.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.